The role of arachidonate lipoxygenase and fatty acids during irreversible blood platelet aggregation in vitro
- 28 February 1981
- journal article
- Published by Elsevier in Prostaglandins and Medicine
- Vol. 6 (2) , 111-126
- https://doi.org/10.1016/0161-4630(81)90081-1
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- A selective thromboxane synthetase inhibitor blocks the cAMP lowering activity of PGH2Biochemical and Biophysical Research Communications, 1977
- Selective inhibition of platelet n — 8 lipoxygenase by 5,8,11-eicosatriynoic acidBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1977
- : A selective inhibitor of thromboxane synthetaseProstaglandins, 1977
- Stimulation of human eosinophil and neutrophil polymorphonuclear leukocyte chemotaxis and random migration by 12-L-hydroxy-5,8,10,14-eicosatetraenoic acid.Journal of Clinical Investigation, 1977
- Biogenesis of chemotactic molecules by the arachidonate lipoxygenase system of plateletsNature, 1975
- Arachidonate lipoxygenase in blood plateletsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1975
- Inhibition by sulfhydryl agents of arachidonic acid-induced platelet aggregation and release of potential inflammatory substancesProstaglandins, 1974
- Formation of an Intermediate in Prostaglandin Biosynthesis and Its Association with the Platelet Release ReactionJournal of Clinical Investigation, 1974
- The measurement of platelet aggregation in small blood samplesAtherosclerosis, 1972
- Non‐enzymic conversion of all‐cis 8,11,14‐eicosatrienoic acid into prostaglandin E1Recueil des Travaux Chimiques des Pays-Bas, 1967